Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities
Cyclophilins play a key role in the life cycle of many viruses and represent important drug targets for broad-spectrum antiviral therapies. Here, the authors use fragment-based drug discovery to develop non-peptidic inhibitors of human cyclophilins with high activity against replication of a number...
Enregistré dans:
Auteurs principaux: | Abdelhakim Ahmed-Belkacem, Lionel Colliandre, Nazim Ahnou, Quentin Nevers, Muriel Gelin, Yannick Bessin, Rozenn Brillet, Olivier Cala, Dominique Douguet, William Bourguet, Isabelle Krimm, Jean-Michel Pawlotsky, Jean- François Guichou |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/39ec7c8e931548f1a43d8bd4de43a06f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice.
par: Stéphane Chevaliez, et autres
Publié: (2009) -
Comparing binding modes of analogous fragments using NMR in fragment-based drug design: application to PRDX5.
par: Clémentine Aguirre, et autres
Publié: (2014) -
Mycobacterium tuberculosis cyclophilin A uses novel signal sequence for secretion and mimics eukaryotic cyclophilins for interaction with host protein repertoire.
par: Asani Bhaduri, et autres
Publié: (2014) -
PpiA, a surface PPIase of the cyclophilin family in Lactococcus lactis.
par: Nicolas Trémillon, et autres
Publié: (2012) -
Cyclophilin A enables specific HIV-1 Tat palmitoylation and accumulation in uninfected cells
par: Christophe Chopard, et autres
Publié: (2018)